1. Kransdorf M.J., Bridges M.D. Current developments and recent advances in musculoskeletal tumor imaging. Semin Musculoskelet Radiol 2013;17(2):145-55. https://doi.org/10.1055/s-0033-1343070.
2. Dorfman H.D., Czerniak B., Kotz R., Vanel D., Park Y.K., Unni K.K. WHO classification of tumours of bone: introduction. In: Fletcher C.D.M., Unni K.K., Mertens F., eds. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. Geneva: IARC Press; 2002. Pp. 227-232.
3. Алиев М.Д., Сушенцов Е.А. Современная онкоортопедия. Саркомы костей, мягких тканей и опухоли кожи 2012;4:3-10.
4. Ewing J. The classic: diffuse endothelioma of bone. Proceedings of the New York Pathological Society. 1921;12:17. Clin Orthop Relat Res 2006;450:25-7. https://doi.org/10.1097/01.blo.0000229311.36007.c7.
5. Эпидемиология злокачественных новообразований у детей: основные показатели в 2011-2016 гг. Под ред. М.Ю. Рыкова, В.Г. Полякова. М.: Первый МГМУ им. И.М. Сеченова, 2017. 208 с.
6. Fletcher C.D., Bridge J.A., Hogendoorn P.C., Mertens F., eds. Pathology and genetics of tumours of soft tissue and bone. Vol. 5. 4th ed. WHO, 2013.
7. Nomikos G.C., Murphey M.D. Primary Bone tumors of lower extremities. Radiol Clin North Am 2002;40(5):971-90. https://doi.org/10.1016/s0033-8389(02)00038-6.
8. Hapani H., Kalola J., Hapani J. Comparative role of CT scan and MR imaging in primary malginant bone tumors. IOSR J Dent Med Sci 2014;13(11):29-35. https://doi.org/10.9790/0853-131173643.
9. Putta T., Gibikote S., Madhuri V., Walter N. Accuracy of Various MRI Sequences in Determining the Tumour Margin in Musculoskeletal Tumours. Pol J Radiol 2016;81:540-8. https://doi.org/10.12659/PJR.898108.
10. Verstraete K.L., Lang P. Bone and Soft Tissue Tumors: The Role of Contrast Agents for MR Imaging. Eur J Radiol 2000;34(3):229-46. https://doi.org/10.1016/s0720-048x(00)00202-3.
11. Verstraete K.L., Van der Woude H.J., Hogendoorn P.C., De Deene Y., Kunnen M., Bloem J.L. Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging 1996;6(2):311-21. https://doi.org/10.1002/jmri.1880060210.
12. Shapeero L.G., Vanel D., Verstraete K.L., Bloem J.L. Dynamic contrast-enhanced MR imaging for soft tissue sarcomas. Semin Musculoskeletal Radiol 1999;3(2):101-13. https://doi.org/10.1055/s-2008-1080055.
13. Shah L.M., Hanrahan C.J. MRI of spinal bone marrow: part I, techniques and normal age-related appearances. Am J Roentgenol 2011;197(6):1298-308. https://doi.org/10.2214/AJR.11.7005.
14. Disler D.G., McCauley T.R., Ratner L.M., Kesack C.D., Cooper J.A. In-phase and out-of-phase MR imaging of bone marrow: prediction of neoplasia based on the detection of coexistent fat and water. Am J Roentgenol 1997;169(5):1439-47. https://doi.org/10.2214/ajr.169.5.9353477.
15. Епифанова С.В., Седых С.А., Тепляков В.В., Карпенко В.Ю., Бухаров А.В., Державин В.В., Шаталов А.М., Мыслевцев И.В. Магнитно-резонансная и компьютерная томография в оценке местной распространенности первичных опухолей костей конечностей. Вестник Российского научного центра рентгенорадиологии Минздрава России 2011;11.
16. Fayad L.M., Bluemke D.A., McCarthy E.F., Weber K.L., Barker P.B., Jacobs M.A. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization. J Magn Reson Imaging 2006;23(1):23-8. https://doi.org/10.1002/jmri.20448.
17. Fayad L.M., Salibi N., Wang X., Machado A.J., Jacobs M.A., Bluemke D.A., Barker P.B. Quantification of muscle choline concentrations by proton MR spectroscopy at 3 T: technical feasibility. Am J Roentgenol 2010;194(1):73-9. https://doi.org/10.2214/AJR.09.3125.
18. Wang C.K., Li C.W., Hsieh T.J., Chien S.H., Liu G.C., Tsai K.B. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results. Radiology 2004;232(2):599-605. https://doi.org/10.1148/radiol.2322031441.
19. Subhawong T.K., Wang X., Durand D.J., Jacobs M.A., Carrino J.A., Machado A.J., Fayad L.M. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions. Am J Roentgenol 2012;198(1):162-72. https://doi.org/10.2214/AJR.11.6505.
20. Hsieh T.J., Li C.W., Chuang H.Y., Liu G.C., Wang C.K. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience. J Comput Assist Tomogr 2008;32(6):987-94. https://doi.org/10.1097/RCT.0b013e31815b9ce9
21. Golfieri R., Baddeley H., Pringle J.S., Leung A.W., Greco A., Souhami R. MRI in primary bone tumors: therapeutic implications. Eur J Radiol 1991;12:201-7. https://doi.org/10.1016/0720-048x(91)90073-5.